chitosan has been researched along with cholic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, ZY; Zhang, Q | 1 |
| Chang, PS; Kim, YS; Lee, HG; Lee, JS; Park, SY; Yoo, SH | 1 |
| Abd ElHady, SS; Awad, GA; Mortada, ND; Zaki, NM | 1 |
| Chirachanchai, S; Ngawhirunpat, T; Opanasopit, P; Ruktanonchai, U; Wasanasuk, K; Wonglertnirant, N; Yoksan, R | 1 |
| Gao, Y; Heng, L; Liu, Y; Pan, Z; Wang, Y; Yao, G | 1 |
| Fan, X; Li, L; Xu, W; Zhao, Y | 1 |
| Ge, Y; Li, L; Zhao, Y | 1 |
| Han, F; Hao, K; Hong, S; Niu, B; Peng, S; Tang, Z; Wang, Z; Zhang, X | 1 |
| Cai, H; Liu, Z; Yao, P; Zhang, Z | 1 |
| Chatterjee, S; Judeh, ZMA | 1 |
| Chen, L; Wang, C; Wu, Y | 1 |
11 other study(ies) available for chitosan and cholic acid
| Article | Year |
|---|---|
[Study on pulmonary delivery of peptide drugs in rats: effects of absorption enhancers on cellular membrane fluidity].
Topics: Absorption; Animals; Biological Availability; Calcitonin; Caprylates; Cell Membrane; Chitin; Chitosan; Drug Synergism; Lung; Male; Membrane Fluidity; Membrane Proteins; Molecular Conformation; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Sodium Cholate | 2003 |
Effects of selective oxidation of chitosan on physical and biological properties.
Topics: Alcohols; Bile Acids and Salts; Biocompatible Materials; Bromides; Chitosan; Cholic Acid; Cyclic N-Oxides; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Macromolecular Substances; Oxygen; Polymers; Sodium Compounds; Sodium Hypochlorite; Solubility; Temperature; Water | 2005 |
Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Topics: Absorption; Administration, Intranasal; Animals; Antiemetics; Biological Availability; Chitosan; Deoxycholic Acid; Erythrocytes; Hemolysis; Humans; L-Lactate Dehydrogenase; Male; Metoclopramide; Nasal Lavage Fluid; Nasal Mucosa; Peptides; Protamines; Proteins; Rats; Rats, Inbred Strains; Sodium Cholate | 2006 |
Incorporation methods for cholic acid chitosan-g-mPEG self-assembly micellar system containing camptothecin.
Topics: Camptothecin; Chitosan; Cholic Acid; Drug Delivery Systems; Half-Life; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Lactones; Methyl Ethers; Micelles; Microscopy, Electron, Transmission; Particle Size; Polyethylene Glycols | 2009 |
Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Chitosan; Cholic Acid; Delayed-Action Preparations; Drug Carriers; Humans; Kinetics; MCF-7 Cells; Micelles; Paclitaxel; Particle Size; Surface-Active Agents | 2013 |
Cysteine modified and bile salt based micelles: preparation and application as an oral delivery system for paclitaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Cell Survival; Chitosan; Cysteine; Drug Carriers; Drug Stability; Humans; Male; MCF-7 Cells; Micelles; Paclitaxel; Poloxamer; Rats; Rats, Wistar; Sodium Cholate; Surface-Active Agents | 2015 |
Preparation of sodium cholate-based micelles through non-covalent ıbonding interaction and application as oral delivery systems for paclitaxel.
Topics: Acrylates; Animals; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Micelles; Paclitaxel; Rats; Sodium Cholate | 2016 |
Enhanced removal of bisphenol-AF onto chitosan-modified zeolite by sodium cholate in aqueous solutions.
Topics: Adsorption; Benzhydryl Compounds; Chitosan; Hydrogen-Ion Concentration; Kinetics; Phenols; Sodium Cholate; Thermodynamics; Water Pollutants, Chemical; Water Purification; Zeolites | 2015 |
Effective Enhancement of Hypoglycemic Effect of Insulin by Liver-Targeted Nanoparticles Containing Cholic Acid-Modified Chitosan Derivative.
Topics: Animals; Chitosan; Cholic Acid; Diabetes Mellitus, Experimental; HEK293 Cells; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Nanoparticles; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared | 2016 |
Impact of the type of emulsifier on the physicochemical characteristics of the prepared fish oil-loaded microcapsules.
Topics: Benzenesulfonates; Capsules; Chemical Phenomena; Chitosan; Deoxycholic Acid; Emulsifying Agents; Emulsions; Fish Oils; Sodium Cholate; Sodium Dodecyl Sulfate | 2017 |
Cholesterol (Blood lipid) lowering potential of Rosuvastatin chitosan nanoparticles for atherosclerosis: Preclinical study in rabbit model.
Topics: Animals; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Biomarkers; Calcinosis; Calcium; Chitosan; Cholesterol; Cholesterol, LDL; Cholic Acid; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Hypercholesterolemia; Interleukin-6; Male; Nanoparticles; Particle Size; Rabbits; Rosuvastatin Calcium; Treatment Outcome | 2020 |